Overall Management > Glial Tumors of Uncertain Origin


Journal of Neuro-Oncology, DOI: 10.1007/s11060-006-9245-7, Published online: 6 September 2006


Abstract

Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri

Stefan Braeuninger1, 5,*, Regine Schneider-Stock2, Elmar Kirches1, James M. Powers3, David N. Korones4 and Christian Mawrin,1,**

1Department of Neuropathology, Otto-von-Guericke-University, Leipziger Str. 44, D-39120  Magdeburg, Germany. 2Department of Pathology, Otto-von-Guericke-University, Leipziger Str. 44, D-39120  Magdeburg, Germany. 3Department of Pathology and Laboratory Medicine, University of Rochester, Rochester, NY, USA. 4Department of Pediatrics, University of Rochester, Rochester, NY, USA. 5Department of Neurology, Julius-Maximilians-University, Wuerzburg, Germany -- *Stefan Braeuninger: Phone: +49-391-6715813, Fax: +49-391-6713300; **Christian Mawrin (Corresponding author) Email: christian.mawrin@medizin.uni-magdeburg.de -- Received: 24 July 2006  Accepted: 9 August 2006  Published online: 6 September 2006.


Gliomatosis cerebri (GC) is a rare tumor characterized by widespread infiltration of the brain and spinal cord. 
Although GC usually demonstrates histomorphological features of a low-grade tumor, the formation of secondary highly malignant tumor regions may occur. 
In order to reveal molecular genetic changes associated with tumor progression in GC, we analyzed factors known to be associated with malignant progression in common astocytomas in an unusual GC case of an 18-year-old patient suffering from this disease for almost 7 years. 
We detected allelic losses in the Rb gene and in exon 4 of the TP53 gene in a tumor region corresponding to a glioblastoma multiforme. 
EGFR or MDM2 gene amplifications were absent, and no PTEN mutation or allelic loss on chromosome 10 could be detected. 
Moreover, compared to tumor-free brain tissue of this patient, tumor regions showed increased EGFR expression. 
These findings show that malignant progression in GC might be associated with the acquisition of molecular genetic changes also found in low-grade astrocytomas with progression to secondary glioblastoma. 
These data support the notion that GC can be regarded as a subtype of a common astrocytoma.

Keywords: Cell cycle regulators, Gliomatosis cerebri, Neurofibromatosis type 1


© 2006 Springer
Abstract


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP